XBiotech signs new executive employment agreement with CEO John Simard
XBiotech entered into an Executive Employment Agreement with CEO and President John Simard, effective October 1, 2025, replacing his prior employment agreements. The agreement sets a $1,250,000 base salary, an annual base bonus of $4,530,442, and severance of three years of salary and bonus if he retires, leaves due to disability, or is terminated without cause.
Key points
- Agreement signed October 2, 2025, effective October 1, 2025, superseding all prior employment agreements with Mr. Simard
- Base salary of $1,250,000 maintained; annual base bonus of $4,530,442, based on the average annual bonus paid over the past five years and determined each year by the Compensation Committee
- Severance of three full calendar years of base salary and base bonus on retirement, disability, or termination without cause, paid in cash within 14 days after the release takes effect
- If Mr. Simard retires, he will consult for the company for at least 18 months and continue receiving base salary during that period
The filing
Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 03, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.